You are here
NCSE congratulates Francisco J. Ayala on winning the Templeton Prize.
As the only national organization that is wholly dedicated to defending the teaching of evolution in the public schools, NCSE is the perfect place to find someone to speak to your organization or university about issues relevant to evolution education and attacks on it. Available speakers include NCSE's executive director Eugenie C. Scott, Glenn Branch, Joshua Rosenau, Steven Newton, Peter M. J. Hess, Louise S. Mead, Eric Meikle, and Philip Spieth, as well as three members of our board of directors, Barbara Forrest, Kevin Padian, and Andrew J. Petto. So if you need a speaker, please feel free to visit the speakers information page on the NCSE website or get in touch with the NCSE office. If nobody from NCSE is available or suitable, we'll try to find you someone who is!
NCSE's archives house a unique trove of material on the creationism/evolution controversy, and we regard it as part of our mission to preserve it for posterity — as well as for occasions such as Kitzmiller v. Dover, where NCSE's archives helped to establish the creationist antecedents of the "intelligent design" movement.
NCSE is pleased to announce the winners of the Friends of Darwin award for 2010: David Hillis, Gerald Skoog, and Ronald Wetherington, all scientists in Texas who have fought for the integrity of science education in the Lone Star State.
Two members of NCSE's staff, education project director Louise S. Mead and executive director Eugenie C. Scott, recently surfaced in the blogosphere — Mead with a guest post on the blog of the National Association of Biology Teachers, and Scott in a question-and-answer session on the La Ciencia y sus Demonios (Science and its Demons) blog.
Writing at the Huffington Post (February 12, 2010), NCSE's Steven Newton offered, in honor of Charles Darwin's 201st birthday, a list of five ways in which evolution is important to medical practice: improving the understanding of H1N1 and emerging diseases, HIV, vaccines, antibiotic resistance, and drug development.